Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05345301 · ClinicalTrials.gov registry record · NA

Safety and Feasibility of eGlove

A NA study, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05345301: Completed NA study, sponsored by Shirley Ryan AbilityLab.

NCT05345301 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05345301, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to measure how cortical signals improve in stroke participants after passive hand stretching therapy from a robotic glove.

Primary Outcome

Sensorimotor neural activity

Interventions

  • DIAGNOSTIC_TEST Event related desynchronization measurement

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-03-28
Est. Completion 2022-09-14
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the finished NCT05345301 record still lists

NCT05345301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Event related desynchronization measurement is the first listed.

NCT05345301 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05345301 about?

NCT05345301 is a clinical study titled "Safety and Feasibility of eGlove". The purpose of this study is to measure how cortical signals improve in stroke participants after passive hand stretching therapy from a robotic glove.

What is the current status of trial NCT05345301?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-03-28. Estimated completion is 2022-09-14.

What interventions are being tested in trial NCT05345301?

The interventions under investigation include: Event related desynchronization measurement (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05345301?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05345301's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05345301, the US trial registry maintained by the National Library of Medicine. NCT05345301 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.